In the SUSTAIN 6 cardiovascular outcomes trial (published in NEJM 2016), semaglutide reduced the risk of major adverse cardiovascular events (MACE) by 26% compared to placebo in patients with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors
Keep a symptom diary noting bowel frequency, consistency (using the NHS Bristol Stool Chart as reference), associated symptoms, and dietary intake
However, some patients respond well at lower doses
Then I was on Ozempic and had terrible stomach pains and didnt lose any weight, so I stopped taking it. M.H., Facebook Feeling Healthier and Happier on Mounjaro I have been using Mounjaro for six months and have lost 49 pounds
Acid reflux, Heartburn, and GERD: Whats the difference